8.22
+0.12(+1.48%)
Currency In USD
| Previous Close | 8.1 |
| Open | 8.08 |
| Day High | 8.4 |
| Day Low | 8.08 |
| 52-Week High | 8.85 |
| 52-Week Low | 4.76 |
| Volume | 150,924 |
| Average Volume | 158,669 |
| Market Cap | 307.97M |
| PE | -6.47 |
| EPS | -1.27 |
| Moving Average 50 Days | 7.78 |
| Moving Average 200 Days | 7.27 |
| Change | 0.12 |
If you invested $1000 in Lifecore Biomedical, Inc. (LFCR) 10 years ago, it would be worth $773.28 as of January 19, 2026 at a share price of $8.22. Whereas If you bought $1000 worth of Lifecore Biomedical, Inc. (LFCR) shares 5 years ago, it would be worth $735.24 as of January 19, 2026 at a share price of $8.22.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lifecore Biomedical to be Added to Nasdaq Biotech Index
GlobeNewswire Inc.
Dec 18, 2025 12:00 PM GMT
CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has been notified by Nasdaq that the co
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer
GlobeNewswire Inc.
Dec 17, 2025 12:00 PM GMT
Agreement Calls for Development Services and Tech Transfer in Preparation for Commercial Manufacturing of Injectable Pharmaceutical Product Partner’s Program Size Positions it to Become a Top Five Commercial Customer for Lifecore CHASKA, Minn., Dec.
Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 16, 2025 12:00 PM GMT
CHASKA, Minn., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 44th A